We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Waters Corporation and Quest Diagnostics have formed a collaboration to broaden access to the FDA-cleared Onclarity Self-Collection Kit. More...
22 Oct 2026
Image: AlzoSure Predict is designed to help clinicians assess the likelihood of Alzheimer’s disease progression in patients with mild cognitive impairment. (Photo courtesy of Diadem)

Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch

A new blood test predicts Alzheimer’s progression up to six years before symptoms by measuring a disease-related protein marker. More...
22 Oct 2026
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

New findings show blood protein profiling years before diagnosis signals prostate cancer risk, More...
22 Oct 2026
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

An AI approach using vision transformers boosts detection of precancerous colon polyps to 70% sensitivity, 86% accuracy. More...
22 Oct 2026
Image Credit: iStock

New Variant Tracking Option Expands Molecular Residual Disease Monitoring

Personalis has launched Real-Time Variant Tracker supplemental results within the NeXT Personal MRD test report. More...
22 Oct 2026
Image: The AI-enabled panel analyzes routine H&E whole-slide images to predict clinically relevant genomic and IHC biomarker status, supporting more timely access to personalized therapies. (Image Credit: Shutterstock)

AI Pre-Screening Helps Identify Lung Cancer Cases for Additional Biomarker Testing

A study of more than 60,000 advanced NSCLC cases found over 80% sensitivity across 12 biomarkers using routine H&E images. More...
22 Oct 2026
Image: Tumor DNA is extracted from a pathology sample, and normal DNA is extracted from the buffy coat. Both samples undergo WGS to generate the patient-specific mutational signature. At each follow-up, ctDNA extracted from plasma undergoes WGS and is analyzed using a patient-derived signature and an artificial intelligence (AI) pattern recognition algorithm. FFPE: formalin fixed, paraffin embedded. (Snuderl M, Smadbeck J, Wilkins R, et al. The Journal of Molecular Diagnostics, 2026. DOI: 10.1016/j.jmoldx.2026.07.003)

Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

A new liquid biopsy detects minimal residual disease and predicts early NSCLC recurrence months before imaging. More...
21 Oct 2026
Visit expo >
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9

In Other News

Copyright © 2000 - 2026 Globetech Media.
All rights reserved.